![]()
|
--->
|
|
|
|
advertisement
|
|
Top Stories
The partnership will center on the development and commercialization of DCR-HBVS, Dicerna’s investigational therapy in Phase I clinical development, using its proprietary RNAi platform technology.
/ read more /
The project will seek to deliver treatments for the underlying cause of cystic fibrosis through submitted proposals from potential collaborators..
/ read more /
|
|
|
|
advertisement
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers
|
 |
|
|
|
|
Industry News
Published on Oct. 29, 2019, the study focuses on the multidrug-resistant bacterium Pseudomonas aeruginosa (P. aeruginosa) and how it can be used to develop new and sustainable antibiotic treatments.
/ read more /
Start-up company, SeraNovo, has revealed that it has signed a license agreement with Carna Biosciences to expand the existing collaboration and jointly develop an oral formulation of Carna’s kinase inhibitor with increase bioavailability.
/ read more /
More Industry News
|
|
Supplier News
The new Javené, France-based facility is expected to increase the company’s production capacity of injectable grade sodium hyaluronate obtained by fermentation by 2.5 times.
/ read more /
The companies will develop innovative formulations for drugs to treat rare diseases using Catalent’s oral disintegrating tablet technologies.
/ read more /
More Supplier News
|
|
|
advertisement
|
|
advertisement
|
|
advertisement
|
|
|
|
Bio/Pharma News
Breaking with tradition, a compounding facility won for overall operational excellence, while biopharma facilities took home awards in various categories.
/ read more /
FDA has approved Vumerity (diroximel fumarate), a new oral drug for relapsing forms of multiple sclerosis.
/ read more /
More Bio/Pharma News
|
|
|
Regulatory News
Showing gains of 54% compared with 2018, results from a 2019 study showed that nearly three-quarters of pharma barcodes meet Drug Supply Chain Security Act requirements.
/ read more /
The report focuses on information from stakeholders, published research, and economic analysis of market conditions from an analysis of drug shortage data and development of recommendations by the inter-agency Drug Shortage Task Force led by FDA.
/ read more /
More Regulatory News
|
|
|
|
FORMULATION
New approaches seek to address formulation and delivery challenges for these complex molecules.
/ read more /
|
|
|
|
MANUFACTURING
Although continuous approaches offer significant benefits for some products and processes, batch manufacturing is not going away any time soon.
/ read more /
|
|
|
|
PEER-REVIEWED RESEARCH
It is important to address manufacturing problems associated with the shorter shelf-life of pegylated L-asparaginase (pegaspargase) upon long-term storage in the form of a solution.
/ read more /
|
|
|
|
DRUG DELIVERY
Intracellular strategies offer an effective alternative approach to deliver a range of therapeutic proteins.
/ read more /
|
|
|
UPCOMING WEBCASTS
An Integrated Approach to Spray Drying: From Scale-Up to Manufacturing
November 19, 2019 at 11am EST | 8am PST | 4pm GMT | 5pm CET
 Register Now
Replacing Settle Plates with Active Air Sampling
Wednesday, November 13, 2019 at 10am EST | 9am CST | 3pm GMT | 4pm CET
 Register Now
Events
November 12–13, 2019
November 25–26, 2019
December 4–5, 2019
more events
|
|
|
eBOOKS
 |
The editors explore novel technologies for the formulation, manufacture,
purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.
|
|
|
|
|
|
Learn More
Learn More
Learn More
Learn More
Learn More
Learn More
Learn More
Learn More